Rheumatology Advance Access originally published online on October 12, 2004
Rheumatology 2005 44(1):111-119; doi:10.1093/rheumatology/keh417
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology Vol. 44 No. 1 © British Society for Rheumatology 2004; all rights reserved
PAPER |
A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus
ozepartments of Nephrology and 1 Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Correspondence to: M. A. Seelen, Department of Nephrology, C3P-29, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. E-mail: majseelen{at}lumc.nl
Objective. To investigate the possible association of the mannose binding lectin (MBL) pathway of complement activation with different disease parameters and disease activity in patients with systemic lupus erythematosus (SLE).
Methods. MBL genotype, MBL serum concentration, MBL complex activity and MBL pathway activity were assessed in 53 patients. The activity of the MBLMASP complex was assessed on the basis of its ability to activate exogenous C4. For MBL pathway activity the formation of the terminal complex of complement activation (C5b-9) was measured. Results were analysed in relation to clinical variables and autoantibody profiles in these patients.
Results. MBL complex activity and MBL pathway activity were both reduced in patients carrying MBL variant alleles. Anticardiolipin and anti-C1q autoantibodies were observed significantly more frequently in patients with MBL variant alleles. Furthermore, the presence of these autoantibodies was associated with a decreased MBL concentration and function. In contrast, anti-MBL autoantibodies were not found in patients with MBL variant alleles, possibly related to impaired binding of variant MBL to apoptotic material.
Conclusion. In patients with SLE, a reduced functional activity of the MBL pathway of complement, in relation to expression of MBL variant alleles, is associated with increased levels of autoantibodies against cardiolipin and C1q, but not against MBL. We hypothesize that an enhanced production of autoantibodies may be related to disturbed clearance of apoptotic material due to impaired MBL function.
KEY WORDS: Mannose binding lectin, Lectin pathway activity, SLE, Autoantibodies
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Tsai, T. Yao, M. Kuo, T. Cheng, and J. Huang Lack of association of mannose-binding lectin gene polymorphisms with development and clinical manifestations of systemic lupus erythematosus in Chinese children Lupus, April 1, 2009; 18(4): 372 - 376. [Abstract] [PDF] |
||||
![]() |
O. B. Christiansen, H. S. Nielsen, M. Lund, R. Steffensen, and K. Varming Mannose-binding lectin-2 genotypes and recurrent late pregnancy losses Hum. Reprod., February 1, 2009; 24(2): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ramos-Casals, P. Brito-Zeron, N. Soria, N. Nardi, A. Vargas, S. Munoz, A. Bove, B. Suarez, and F. Lozano Mannose-binding lectin-low genotypes are associated with milder systemic and immunological disease expression in primary Sjogren's syndrome Rheumatology, January 1, 2009; 48(1): 65 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Font, M. Ramos-Casals, P. Brito-Zeron, N. Nardi, A. Ibanez, B. Suarez, S. Jimenez, D. Tassies, A. Garcia-Criado, E. Ros, et al. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus Rheumatology, January 1, 2007; 46(1): 76 - 80. [Abstract] [Full Text] [PDF] |
||||


